Molecular Testing for Pancreatic Cancer

Authored by Mike J. Pishvaian, published on 2026-08-06 17:25:56.0

Molecular testing for pancreatic cancer at first visit and within the first 2-4 weeks.

  1. At Diagnosis
    • At the first patient visit
      • Germline Testing 100% of patients Irrespective of disease stage or Family history
      • Liquid NGS Testing For rapid assessment of “actionable” biomarkers
    • Within the first 2-4 weeks
      • Somatic Tumor Testing To include DNA and RNA NGS testing
tosprivacyHealthcare Unfiltered Episode 287 - RAS in Pancreatic Cancer: The RASolute 302 Study